Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
$59.56K
Current Assets
2023 Q2
Current Liabilities
2023 Q2
Current Ratio
2023 Q2
7.18%
Total Assets
2023 Q2
Total Liabilities
2023 Q2
Book Value
2023 Q2
-$2.739M
Cash
2023 Q2
P/E
TTM
1.847
Free Cash Flow
TTM
-$251.0K

Stock Price

Loading...
Market Cap: $110 Thousand

About Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc. operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company is headquartered in De Leon, Texas and currently employs 3 full-time employees. The company went IPO on 2013-10-31. The firm is also focusing on manufacturing its own branded metered dose inhaler (MDI) under the inhaler brand name.

Industry: Pharmaceutical Preparations Peers: Arch Therapeutics, Inc. Nexgel Inc CHEMBIO DIAGNOSTICS, INC. PROCYON CORP Rockwell Medical Inc Sharps Technology Inc Vycor Medical Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support